PROLabels - Patient-Reported Outcomes & drug marketing authorizations

The database is available to pharmaceutical companies, non-profit organizations and universities, and regulatory agencies on a yearly subscription basis. For other for-profit companies, e.g. Contract Research Organizations (CROs) and PRO consulting companies, access is possible based on ad hoc requests.

ERIQA members can benefit from a special rate of € 4,000 for one user.

We also offer a combined access to both PROLabels and PROQOLID our Patient-Reported Outcomes and Quality of Life Instruments Database, at a discounted price of -5% for the second and subsequent subscription.

Subscription fees

The standard fees for one login/password are as follows. (For France, the fees do not include VAT.)

	Standard Fee
	Euros
Pharmaceutical companies (1 user)	5,000
Non-profit organizations and universities (1 user)	1,000
Regulatory agencies (total of 5 users)	1,000
ERIQA member (1 user)	4,000
Other for-profit companies	ad hoc requests

Additional fees for more than one user per subscription are available for pharmaceutical companies.

Users	2	3	4	5	10	15	20	30	40	50-100
Euros	7,000	8,400	9,700	10,700	15,000	18,000	19,500	20,500	21,000	22,000

How to subscribe

For more information on, or to subscribe to the PROLabels database, please contact:

   Mapi Research Trust
   Martine Caron
   Literature Reviews & Databases Unit Team Manager
   27 rue de la Villette
   69003 LYON – France
   Tel.: +33 (0) 472 13 65 75
   Fax: +33 (0)4 72 13 66 82
   E-mail : mcaron@mapigroup.com